189 related articles for article (PubMed ID: 25192287)
21. Targeting the Ang2/Tie2 Axis with Tanshinone IIA Elicits Vascular Normalization in Ischemic Injury and Colon Cancer.
Zou W; Qian C; Zhang S; Wan X; Wei Z; Li X; Wu Y; Chen W; Wang A; Zhao Y; Lu Y
Oxid Med Cell Longev; 2021; 2021():7037786. PubMed ID: 34804370
[TBL] [Abstract][Full Text] [Related]
22. Tanshinone IIA inhibits BT-20 human breast cancer cell proliferation through increasing caspase 12, GADD153 and phospho-p38 protein expression.
Yan MY; Chien SY; Kuo SJ; Chen DR; Su CC
Int J Mol Med; 2012 May; 29(5):855-63. PubMed ID: 22322382
[TBL] [Abstract][Full Text] [Related]
23. Tanshinone IIA alleviates acute ethanol-induced myocardial apoptosis mainly through inhibiting the expression of PDCD4 and activating the PI3K/Akt pathway.
Deng H; Yu B; Li Y
Phytother Res; 2021 Aug; 35(8):4309-4323. PubMed ID: 34169595
[TBL] [Abstract][Full Text] [Related]
24. Tanshinone IIA induces mitochondria dependent apoptosis in prostate cancer cells in association with an inhibition of phosphoinositide 3-kinase/AKT pathway.
Won SH; Lee HJ; Jeong SJ; Lee HJ; Lee EO; Jung DB; Shin JM; Kwon TR; Yun SM; Lee MH; Choi SH; Lü J; Kim SH
Biol Pharm Bull; 2010; 33(11):1828-34. PubMed ID: 21048307
[TBL] [Abstract][Full Text] [Related]
25. Tanshinone IIA attenuates renal injury during hypothermic preservation via the MEK/ERK1/2/GSK-3β pathway.
Xu L; Xu Y; Zhu Z; Gu H; Chen C; Chen J
BMC Complement Med Ther; 2021 Oct; 21(1):257. PubMed ID: 34625061
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory effect of tanshinone IIA on rat hepatic stellate cells.
Liu YW; Huang YT
PLoS One; 2014; 9(7):e103229. PubMed ID: 25076488
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effect of Tanshinone IIA on inverted formin-2 protects HaCaT cells against oxidative injury via regulating mitochondrial stress.
Xie Z; Zhou Y; Duan X; Yang L
J Recept Signal Transduct Res; 2019 Apr; 39(2):134-145. PubMed ID: 31354004
[No Abstract] [Full Text] [Related]
28. Tanshinone IIA ameliorates cognitive deficits by inhibiting endoplasmic reticulum stress-induced apoptosis in APP/PS1 transgenic mice.
He Y; Ruganzu JB; Lin C; Ding B; Zheng Q; Wu X; Ma R; Liu Q; Wang Y; Jin H; Qian Y; Peng X; Ji S; Zhang L; Yang W; Lei X
Neurochem Int; 2020 Feb; 133():104610. PubMed ID: 31778727
[TBL] [Abstract][Full Text] [Related]
29. Tanshinone IIA reduces SW837 colorectal cancer cell viability via the promotion of mitochondrial fission by activating JNK-Mff signaling pathways.
Jieensinue S; Zhu H; Li G; Dong K; Liang M; Li Y
BMC Cell Biol; 2018 Sep; 19(1):21. PubMed ID: 30253740
[TBL] [Abstract][Full Text] [Related]
30. Tanshinone IIA inhibits Hep-J5 cells by increasing calreticulin, caspase 12 and GADD153 protein expression.
Cheng CY; Su CC
Int J Mol Med; 2010 Sep; 26(3):379-85. PubMed ID: 20664954
[TBL] [Abstract][Full Text] [Related]
31. Growth inhibition and apoptosis induction by tanshinone I in human colon cancer Colo 205 cells.
Su CC; Chen GW; Lin JG
Int J Mol Med; 2008 Nov; 22(5):613-8. PubMed ID: 18949381
[TBL] [Abstract][Full Text] [Related]
32. Tanshinone IIA protects PC12 cells from β-amyloid(25-35)-induced apoptosis via PI3K/Akt signaling pathway.
Dong H; Mao S; Wei J; Liu B; Zhang Z; Zhang Q; Yan M
Mol Biol Rep; 2012 Jun; 39(6):6495-503. PubMed ID: 22314911
[TBL] [Abstract][Full Text] [Related]
33. Tanshinone IIA inhibits gastric carcinoma AGS cells through increasing p-p38, p-JNK and p53 but reducing p-ERK, CDC2 and cyclin B1 expression.
Su CC
Anticancer Res; 2014 Dec; 34(12):7097-110. PubMed ID: 25503137
[TBL] [Abstract][Full Text] [Related]
34. Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K/AKT/mTOR pathway.
Zhou J; Jiang YY; Chen H; Wu YC; Zhang L
Cell Prolif; 2020 Feb; 53(2):e12739. PubMed ID: 31820522
[TBL] [Abstract][Full Text] [Related]
35. Tanshinone ⅡA inhibits homocysteine-induced proliferation of vascular smooth muscle cells via miR-145/CD40 signaling.
Li Y; Chen F; Guo R; Jia S; Li W; Zhang B
Biochem Biophys Res Commun; 2020 Jan; 522(1):157-163. PubMed ID: 31757424
[TBL] [Abstract][Full Text] [Related]
36. Tanshinone IIA modulates cancer cell morphology and movement via Rho GTPases-mediated actin cytoskeleton remodeling.
Liang EY; Huang MH; Chen YT; Zhang PW; Shen Y; Tu XX; Chen WY; Wang Y; Yan J; Wang HY; Ke PF; Huang XZ
Toxicol Appl Pharmacol; 2024 Feb; 483():116839. PubMed ID: 38290667
[TBL] [Abstract][Full Text] [Related]
37. Tanshinone IIA decreases the migratory ability of AGS cells by decreasing the protein expression of matrix metalloproteinases, nuclear factor κB-p65 and cyclooxygenase-2.
Su CC
Mol Med Rep; 2016 Feb; 13(2):1263-8. PubMed ID: 26648518
[TBL] [Abstract][Full Text] [Related]
38. Tanshinone IIA inhibits human breast cancer MDA-MB-231 cells by decreasing LC3-II, Erb-B2 and NF-κBp65.
Su CC; Chien SY; Kuo SJ; Chen YL; Cheng CY; Chen DR
Mol Med Rep; 2012 Apr; 5(4):1019-22. PubMed ID: 22246196
[TBL] [Abstract][Full Text] [Related]
39. Tanshinone IIA induces autophagic cell death via activation of AMPK and ERK and inhibition of mTOR and p70 S6K in KBM-5 leukemia cells.
Yun SM; Jung JH; Jeong SJ; Sohn EJ; Kim B; Kim SH
Phytother Res; 2014 Mar; 28(3):458-64. PubMed ID: 23813779
[TBL] [Abstract][Full Text] [Related]
40. Tanshinone IIA combined with adriamycin inhibited malignant biological behaviors of NSCLC A549 cell line in a synergistic way.
Xie J; Liu JH; Liu H; Liao XZ; Chen Y; Lin MG; Gu YY; Liu TL; Wang DM; Ge H; Mo SL
BMC Cancer; 2016 Nov; 16(1):899. PubMed ID: 27863471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
